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Abstract 
Spontaneous regression of basal cell carcinoma (BCC) is rare, and characterized by various 
tumor-infiltrating lymphocytes (TILs) in the tumor. A previous report suggested that these 
infiltrated lymphocytes consist of type 1 helper T cells, but no detailed phenotypical analysis 
of other TILs has been demonstrated yet. In this report, we describe an 84-year-old Japanese 
patient with spontaneous regression of BCC. In the present case, we investigated the 
immunohistochemical profiles of TILs, not only focusing on the cytotoxic T cells, but the 
profiles of immunosuppressive cells, such as regulatory T cells and tumor-associated 
macrophages. Our present study sheds light on the immunological mechanisms of tumor 
rejection in human BCC. 
 
Introduction 
Spontaneous regression of cutaneous tumors has been documented previously, but 
reports of partial spontaneous regression of basal cell carcinoma (BCC) are rare [1]. A 
number of factors are known to contribute to the development of BCC. Recently, the 
role of immunological factors and angiogenic factors in BCC has been investigated, 
especially focusing on regulatory T cells (Tregs), immunosuppressive macrophages and 
matrix metalloproteinase [2–4]. 
Immunological tolerance of self-antigens is essential for the prevention of 
autologous reactions and autoimmune diseases. In the peripheral organs, tolerance is  
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reinforced by a variety of mechanisms, including a population of Tregs, tumor-
associated macrophages (TAMs), myeloid-derived suppressor cells (MDSC), and 
CD163+ M2 macrophages [5–7]. To evaluate the tumor microenvironment from an 
immunological point of view, not only assessing the tumor-infiltrating cytotoxic T cells, 
such as TIA1+, CD8+ T cells, but also investigating these immunosuppressive cells is 
mandatory. In this report, we describe a case of BCC with spontaneous regression and 
employed immunohistochemical staining to verify the tumor-infiltrating lymphocytes 
(TILs), with special focus on the profiles of T cell subsets and tumor-infiltrating 
macrophages. 
Case Report 
An 84-year-old Japanese man visited our outpatient clinic with a ten-year history of an 
asymptomatic, pigmented nodule on his breast. On his initial visit, physical examination revealed a 
brown-colored, elastic-hard, well-demarcated nodule with prominent teleangiectasia and erythema 
on the right breast (fig. 1). The tumor mass was 10 × 8 mm in size. Dermatoscopic finding revealed 
that a prominent large blue-gray ovoid nest and multiple blue-gray globules accompanied by 
arborizing vessels in the peripheral tumor areas were surrounding the blue-whitish area with dotted 
or arborizing vessels areas in the center of the tumor (fig. 1b). We excised the tumor with a 3-mm 
surgical margin from the erythema. Histologically, in the remaining tumor area (fig. 2a), a palisaded 
basophilic tumor island was surrounded by infiltrating lymphocytes. At the center of the tumor, 
eosinophilic collagen was prominent. In the tumor-regressing area (fig. 2b), numerous melanophages 
surrounded the eosinophilic collagen and, at this area, lymphocytes were densely infiltrating through 
the dermis. 
From the above data, we diagnosed this patient as having BCC with spontaneous regression. To 
further investigate the mechanisms of spontaneous regression, we employed immunohistochemical 
staining, especially focusing on the cytotoxic T cells and immunosuppressive lymphocytes. To 
evaluate the infiltrating cells in the tumor-regressing area, we performed immunohistochemical 
stainings in regressive (fig. 3) or tumoral areas (fig. 4) of BCC for CD3, CD4, CD8, TIA1, Foxp3, CD56, 
CD68, CD163 and MMP-9, which revealed that these densely infiltrating mononuclear cells were 
mainly CD3+ (fig. 3a, fig. 4a) and, CD4+, CD8+ (fig. 3b, fig. 4b) and TIA-1+ cells (fig. 3e, fig. 4e). CD68+, 
CD163+ (fig. 3c, fig. 4c) and MMP-9+ (fig. 3d, fig. 4d) cells were detected mainly around melanophages. 
Few Foxp3high+ cells (fig. 3f, fig. 4f) and CD56+ cells were scattered in the CD3+ area. The number of 
immunoreactive cells were counted using an ocular grid of 1 cm2 at a magnification of 400, and 
summarized in fig. 5. Staining of infiltrated lymphocytes was examined in more than 5 random, 
representative fields from each section. Data are expressed as the mean ± standard deviation for Treg 
fractions in each skin disorder. For a single comparison of 2 groups, Student’s t test was used. The 
level of significance was set at p = 0.05. 
Discussion 
With regards to cutaneous tumors, particularly melanoma, there is evidence 
suggesting that the immune system plays a central role in mediating tumor regression 
[1]. However, published studies analyzing the mechanisms underlying spontaneous 
regression in BCCs are few. 
Histological criteria for the regression of BCC were described as follows [1]. The 
criteria for active regression of BCC include the normal palisaded outline of some 
tumor islands, accompanied by a lymphocytic infiltrate penetrating and surrounding 
the tumor nest. The criteria of previous regression were as follows: (i) new eosinophilic 
collagen in the dermis; (ii) reduction in the skin appendages in the areas of scarring;  
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(iii) an increased number of blood vessels; (iv) a variable infiltrate of lymphocytes and 
plasma cells [1, 8]. According to these criteria, our present case mainly appeared to 
represent active regression and, in some parts, contained previous regression patterns. 
As we previously reported concerning the profiles of TILs in metastatic malignant 
melanomas, regressing tumors induce cytotoxic T cells [9]. Concerning BCC, Hunt et al. 
[1] previously investigated the TILs in regressing and non-regressing BCCs and 
reported that significant numbers of CD3+, CD4+ and CD25+ cells were increased in 
regressing compared with non-regressing tumors. They concluded that cytokines from 
activated CD4+ cytokine-secreting cells were important in the regression of BCC. 
Recently, Wong et al. [10] reported that the expression of interferon gamma was 
significantly elevated in actively regressing BCCs compared with non-regressing BCCs, 
which suggested the induction of a Th1 cytokine-mediated antitumor immune 
response. More recently, several reports shed light on the effect of immunosuppressive 
cells, such as CD163+ M2 macrophages and Tregs on the carcinogenesis of BCC [2, 3]. 
Indeed, Tjiu et al. [2] reported that TAMs in BCC are correlated with the depth of 
invasion, microvessel density, and cyclooxygenase-2 expression in tumor. About Tregs, 
Kaporis et al. [3] indicated that CD4+CD25+Foxp3+ Tregs surrounded epithelial tumor 
aggregate in BCC and contributed to maintain a Th2-dominant tumor 
microenvironment. More recently, we demonstrated the effect of depletion of Tregs on 
the activation of both CD4+ and CD8+ T cells in murine melanoma models in 
cooperation with the suppression of MDSC [11]. Indeed, the depletion of Tregs in ret 
melanoma significantly decreases the expression of B7-H1 on MDSC, which is one of the 
functional molecules of MDSC for the suppression of T cell proliferation. In aggregate, 
together with other suppressor cells, such as MDSCs, TAMs and CD163+ M2 
macrophages, Tregs promote an immunosuppressive environment in the tumor-
bearing host [2, 3, 5, 11]. In our present case, few Foxp3+ cells were detected and 
numerous TIA1+ cells were infiltrating through the dermis. Immunosuppressive 
CD163+ M2 macrophages and MMP-9+ cells were also detected, however, in contrast to 
cytotoxic T cells, these cells were observed only around the rest of the tumor cells. 
In summary, we describe a case of BCC with spontaneous regression. Our present 
study sheds light on the immunological mechanisms of tumor rejection in human skin 
cancer and might suggest a possible therapy for such skin tumors by modifying the 
tumor microenvironment. 
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Fig. 1. A brown-colored, elastic-hard, well-demarcated nodule with prominent teleangiectasia and 
erythema on the right breast (a). A prominent large blue-gray ovoid nest and multiple blue-gray 
globules accompanied by arborizing vessels in the peripheral tumor areas were surrounding the 
blue-whitish area with dotted or arborizing vessel areas in the center of the tumor (b). 
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Fig. 2. Palisaded basophilic tumor island was surrounded by infiltrated lymphocytes and, at the 
center of the tumor, eosinophilic collagen is prominent (a). Numerous melanophages surrounded the 
eosinophilic collagen and, at this area, lymphocytes were densely infiltrating through the dermis (b). 
a Peripheral lesion of the tumor. b Center of the tumor. Original magnification 200×. 
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Fig. 3. Regression areas. Paraffin-embedded tissue samples from the patient were stained as follows: 
the sections were developed with new fuchsin for CD3 (a), CD8 (b), CD163 (c), MMP-9 (d), TIA1 (e), 
and Foxp3 (f). Original magnification 100× (a–d), 200× (e, f). 
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Fig. 4. Tumoral area. Paraffin-embedded tissue samples from the patient were stained as follows: the 
sections were developed with new fuchsin for CD3 (a), CD8 (b), CD163 (c), MMP-9 (d), TIA1 (e), and 
Foxp3 (f). Original magnification 200× (a–e), 400× (f). 
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Fig. 5. Summary of the numbers of immunoreactive cells in regressive or tumoral area of BCC. Three 
representative fields of each section were selected from both the epidermis and the dermis 
associated with dense dermal lymphoid infiltrate. The number of immunoreactive cells was counted 
using an ocular grid of 1 cm2 at a magnification of 400×. The data are expressed as the means SD of 
the numbers in each area. * p < 0.05. 
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